期刊文献+

人载脂蛋白A-Ⅰ半胱氨酸突变体的二级结构和脂质结合能力的比较

Comparison of Secondary Structure and Capabilities of Lipid Binding Between Different Cysteine Mutants of Apolipoprotein A-Ⅰ
下载PDF
导出
摘要 为探讨人载脂蛋白A-Ⅰ(apoA-Ⅰ,apolipoproteinA-Ⅰ)α螺旋不同位点的半胱氨酸突变后,对蛋白二级结构和脂质结合能力的影响,利用定点诱变技术构建apoA-Ⅰ的天然半胱氨酸突变体apoA-ⅠMilano(R173C),及其它α螺旋片段上的半胱氨酸突变体,分别为apoA-Ⅰ(S52C),apoA-Ⅰ(N74C),apoA-Ⅰ(L107C),apoA-Ⅰ(K129C),和apoA-Ⅰ(L195C).观察比较各种野生型及突变apoA-Ⅰ单体蛋白的α螺旋含量和二级结构稳定性及其脂质结合能力.结果显示,野生型apoA-Ⅰ,apoA-Ⅰ(S52C),apoA-Ⅰ(N74C),apoA-Ⅰ(L107C),apoA-Ⅰ(K129C),apoA-ⅠMilano和apoA-Ⅰ(L195C)的α螺旋含量分别为54±4%,49±4%,50±2%,51±6%,56±4%,52±3%,和54±1%,各种蛋白的α螺旋含量无显著性差异(P>0.05).野生型apoA-Ⅰ的变性标准自由能(ΔG0D)为10.5kJ/mol;apoA-Ⅰ(S52C)和apoA-ⅠMilano的ΔG0D比野生型低2.1kJ/mol;而apoA-Ⅰ(K129C)的ΔG0D比野生型apoA-Ⅰ高1.6kJ/mol.与野生型apoA-Ⅰ相比,apoA-Ⅰ(K129C)和apoA-Ⅰ(L195C)两个突变体与脂质结合能力明显下降(P<0.05),而其它半胱氨酸突变体(包括apoA-ⅠMilano)在脂质结合动力学方面与野生型apoA-Ⅰ无明显差异.以上结果提示,不同位点发生的半胱氨酸突变对apoA-Ⅰ单体蛋白的α螺旋含量无明显影响,但对蛋白的二级结构稳定性和脂质结合能力影响不尽相同. To explore the influences of cysteine mutations at the different sites of helices upon the secondary structural and functional properties of human apolipoprotein A- Ⅰ (apoA- Ⅰ ), site-directed mutagenesis was employed to construct the natural (apoA- Ⅰ Milano, R173C) or unnatural cysteine mutants of apoA- Ⅰ , named as apoA-Ⅰ (S52C), apoA-Ⅰ (N74C), apoA-Ⅰ(L107C), apoA-Ⅰ (K129C), and apoA-Ⅰ (L195C), respectively. For the recombinant proteins, the a helical contents, the secondary structural stability and the capabilities to bind to lipid were investigated, respectively. The results showed that the a helical contents of the monomeric wild type apoA-Ⅰ , apoA-Ⅰ (S52C), apoA- Ⅰ (N74C), apon- Ⅰ (L107C), apoA-Ⅰ(K129C), and apoA-Ⅰ(L195C)were 54 ± 4%,49 ± 4%,50 ± 2%,51 ± 6%,56 ± 4%,52 ± 3%,and 54 ± 1%, respectively. There were no statistical significances between them ( P 〉 0.05). The free energy of denaturation (△GD^0) of wild type apoA-Ⅰ was 10.5 kJ/mol. △GD^0 of apoA-Ⅰ(S52C)and apoA-Ⅰ Milano decreased by 2.1 kJ/mol and △GD^0 of apoA-Ⅰ(K129C)increased by 1.6 kJ/mol, when compared with wild type apoA-Ⅰ. Binding capacity of apoA-Ⅰ(K129C) and apoA-Ⅰ(L195C)to lipid exhibited significantly lower affinity lipid than that of wild type apoA-Ⅰ (P 〈 0.05), whereas there was no significant difference between the other cysteine mutants (including apoA-Ⅰ Milano ) and the wild type (P 〉 0.05) has been observed. These results indicate that the cysteine mutations at the different sites have not significant effect on the α helical content of apoA-Ⅰ, but have different influence on its secondary structural stability and its ability to bind to lipids.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2005年第5期603-609,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家重点基础研究"973"项目资助(G2000056902) 国家自然科学基金(No.39970170)资助~~
关键词 人载脂蛋白A—Ⅰ 半胱氨酸突变体 α螺旋含量 二级结构稳定性 脂质结合能力 apolipoprotein A- Ⅰ , cysteine mutant, a helical content, secondary structural stability, capability of lipid binding
  • 相关文献

参考文献18

  • 1Weisgraber K H, Rall S C Jr, Bersot T P, Mahley R W, Franceschini G, Sirtori C R. Apolipoprotein A- Ⅰ Milano. Detection of normal A- Ⅰ in affected subjects and evidence for a cysteine for arginine substitution in the variant A- Ⅰ . J Biol Chem, 1983, 258(4): 2508 ~ 2513.
  • 2Sirtori C R, Calabresi L, Franceschini G, Baldassarre D, Amato M,Johansson J, Salvetti M, Monteduro C, Zulli R, Muiesan M L, AgabitiRosei E. Cardiovascular status of carriers of the apolipoprotein A- Ⅰ (Milano) mutant: the Limone sul Garda study. Circulation, 2001, 103 (15): 1949~ 1954.
  • 3Nissen S E, Tsunoda T, Tuzcu E M, Schoenhagen P, Cooper C J, Yasin M, Eaton G M, Lauer M A, Sheldon W S, Grines C L, Halpern S, Crowe T, Blankenship J C, Kerensky R. Effect of recombinant ApoA-Ⅰ Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. J Am Med Assoc, 2003, 290(17): 2292 ~ 2300.
  • 4Shah P K, Yano J, Reyes O, Chyu K Y, Kaul S, Bisgaier C L, Drake S, Cercek B. High-dose recombinant apolipoprotein A-Ⅰ (milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation, 2001, 103 (25): 3047 ~ 3050.
  • 5Chiesa G, Monteggia E, Marchesi M, Lorenzon P, Laucello M, Lorusso V, Di Mario C, Karvouni E, Newton R S, Bisgaier C L, Franceschini G, Sirtori C R. Recombinant apolipoprotein A- Ⅰ (Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res, 2002, 90(9): 974 ~ 980.
  • 6Kaul S, Rukshin V, Santos R, et al. Intramural delivery of recombinant apolipoprotein A-Ⅰ Milano/phospholipid complex (ETC 216) inhibits in-stent stenosis in porcine coronary arteries. Circulation, 2003, 107(20): 2551 ~ 2554.
  • 7Isacchi A, Sarmientos P, Lorenzetti R, Soria M. Mature apolipoprotein AI and its precursor proapoAI: influence of the sequence at the 5' end of the gene on the efficiency of expression in Escherichia coli. Gene, 1989, 81(1): 129 ~ 137.
  • 8Ke S H, Madison E L. Rapid and efficient site-directed mutagenesis by single-tube ‘megaprimer' PCR method. Nucleic Acids Res, 1997, 25(16): 3371 ~ 3372.
  • 9Chen Y H, Yang J T, Martinez H M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry, 1972, 11(22): 4120~ 4131.
  • 10Sparks D L, Lund-Katz S, Phillips M C. The charge and structuralstability of apolipoprotein A- Ⅰ in discoidal and spherical recombinant high density lipoprotein particles. J Biol Chem, 1992, 267 ( 36 ):25839 ~ 25847.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部